UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 308

Sortiert nach

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

European urology, 2021-01, Vol.79 (1), p.62-79

2021

Volltextzugriff (PDF)

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

European urology, 2022-01, Vol.81 (1), p.75-94

2022

Volltextzugriff (PDF)

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

European urology, 2018-01, Vol.73 (1), p.111-122

2018

Volltextzugriff (PDF)

Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1935-1944

2016

Volltextzugriff (PDF)

Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

European urology, 2018-06, Vol.73 (6), p.925-933

2018

Volltextzugriff (PDF)

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

European urology, 2015-11, Vol.68 (5), p.868-879

2015

Volltextzugriff (PDF)

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

International journal of urology, 2011-02, Vol.18 (2), p.113-120

Sylvester, Richard J

2011

Volltextzugriff (PDF)

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

European urology, 2016-12, Vol.70 (6), p.1052-1068

2016

Volltextzugriff (PDF)

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

European urology, 2009-09, Vol.56 (3), p.430-442

2009

Volltextzugriff (PDF)

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

European urology focus, 2019-03, Vol.5 (2), p.205-223

2019

Volltextzugriff (PDF)

Prospective cohort study of long-term neurological outcomes in retired elite athletes: the Advanced BiomaRker, Advanced Imaging and Neurocognitive (BRAIN) Health Study protocol

BMJ open, 2024-04, Vol.14 (4), p.e082902-e082902

2024

Volltextzugriff (PDF)

Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer

European urology, 2012-12, Vol.62 (6), p.1088-1096

2012

Volltextzugriff (PDF)

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

European urology, 2017-03, Vol.71 (3), p.447-461

2017

Volltextzugriff (PDF)

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

European urology, 2002-05, Vol.41 (5), p.523-531

2002

Volltextzugriff (PDF)

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

Urology (Ridgewood, N.J.), 2005-12, Vol.66 (6 Suppl 1), p.90-107

2005

Volltextzugriff (PDF)

Natural history, recurrence, and progression in superficial bladder cancer

TheScientificWorld, 2006-01, Vol.6, p.2617-2625

Sylvester, Richard J

2006

Volltextzugriff (PDF)

Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1688-1697

2001

Volltextzugriff (PDF)

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

European urology, 2013-10, Vol.64 (4), p.639-653

2013

Volltextzugriff (PDF)

A “CONSORT’d” Effort to Improve the Reporting of Urological Randomized Controlled Trials

European urology, 2016-12, Vol.70 (6), p.1050-1051

Sylvester, Richard J

2016

Volltextzugriff (PDF)

How Well Can You Actually Predict Which Non–Muscle-Invasive Bladder Cancer Patients Will Progress?

European urology, 2011-09, Vol.60 (3), p.431-433

Sylvester, Richard J

2011

Volltextzugriff (PDF)

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

European urology, 2006-03, Vol.49 (3), p.466-477

2006

Volltextzugriff (PDF)

Maintenance Bacillus Calmette-Guérin Therapy: The Search for the Optimum Treatment Schedule Continues

European urology, 2015-08, Vol.68 (2), p.263-264

Sylvester, Richard J

2015

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(260)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(182)
Humans
(147)
Urology & Nephrology
(81)
Biological And Medical Sciences
(70)
Female
(63)
Medical Sciences
(61)
Male
(58)
Urology
(49)
Middle Aged
(43)
Aged
(41)
Prognosis
(39)
Urinary Bladder Neoplasms - Pathology
(39)
Oncology
(36)
Urinary Bladder Neoplasms - Drug Therapy
(33)
Adult
(30)
Neoplasm Staging
(30)
Treatment Outcome
(29)
Administration, Intravesical
(24)
Retrospective Studies
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

Prospective cohort study of long-term neurological outcomes in retired elite athletes: the Advanced BiomaRker, Advanced Imaging and Neurocognitive (BRAIN) Health Study protocol

Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer

Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

Natural history, recurrence, and progression in superficial bladder cancer

Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

A “CONSORT’d” Effort to Improve the Reporting of Urological Randomized Controlled Trials

How Well Can You Actually Predict Which Non–Muscle-Invasive Bladder Cancer Patients Will Progress?

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Maintenance Bacillus Calmette-Guérin Therapy: The Search for the Optimum Treatment Schedule Continues

Suchergebnisse filtern